Immix Biopharma, Inc.
IMMX
$1.95
-$0.08-3.94%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -10.20% | -17.87% | -18.23% | 67.44% | -10.58% |
| Total Receivables | -0.05% | -0.25% | -2.19% | 72.73% | 79.65% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -51.65% | -17.06% | -9.05% | 31.56% | -45.00% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -11.51% | -65.50% | -39.61% | 292.83% | -73.29% |
| Total Current Assets | -11.24% | -16.74% | -16.97% | 66.34% | -11.39% |
|
|
|||||
| Total Current Assets | -11.24% | -16.74% | -16.97% | 66.34% | -11.39% |
| Net Property, Plant & Equipment | 15.39% | 59.33% | 5.16% | 2,712.55% | 25.19% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 0.00% | 0.00% | 0.00% | -76.61% | -15.50% |
| Total Assets | -8.73% | -12.81% | -16.05% | 72.38% | -11.34% |
|
|
|||||
| Total Accounts Payable | 63.85% | 40.14% | -33.20% | 145.15% | -8.49% |
| Total Accrued Expenses | 0.63% | 113.23% | -28.57% | -7.83% | 81.72% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 3.99% | 29.55% | 41.11% | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 32.33% | 68.24% | -31.02% | 51.99% | 31.72% |
|
|
|||||
| Total Current Liabilities | 32.33% | 68.24% | -31.02% | 51.99% | 31.72% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -1.63% | -1.58% | -1.52% | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 27.74% | 53.51% | -26.37% | 80.44% | 31.72% |
|
|
|||||
| Common Stock & APIC | 0.80% | 0.84% | 0.39% | 24.10% | 2.40% |
| Retained Earnings | -6.85% | -11.34% | -7.49% | -9.85% | -10.53% |
| Treasury Stock & Other | -209.66% | 441.76% | 265.05% | -129.68% | 165.23% |
| Total Common Equity | -24.50% | -26.54% | -14.41% | 70.16% | -17.04% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -24.50% | -26.54% | -14.41% | 70.16% | -17.04% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -40.46% | -61.75% |
| Total Equity | -24.50% | -26.54% | -13.54% | 70.53% | -17.54% |
|
|
|||||